THC
19%
CBD
0.6%
Genetics Split
Sonoma Coma is a 70% sativa-dominant hybrid with THC testing up to 19 percent, a solid mid-range potency reading.
No effect, terpene, flavor or medical-use data specific to Sonoma Coma has been published yet, so we don't guess. For what hybrid strains usually do, see the effects guide.
THC in this profile
19% THC
About Sonoma Coma
Sonoma Coma splits its genetics 30 percent indica to 70 percent sativa. THC tests up to 19 percent, a respectable middle-of-the-road number that neither undersells nor oversells this strain's potency relative to other sativa-leaning hybrids in circulation. The name itself pairs a well-known Northern California growing region with a word implying total sedation, an interesting contrast for a plant carrying more sativa genetics than indica in its makeup, and one that leaves plenty of room for curiosity about how the two halves of that identity actually resolve in practice. With a clear 70 percent sativa lean and a THC ceiling just under 20 percent, Sonoma Coma sits in a fairly common but reliably potent bracket among sativa-dominant hybrids, distinguished mostly by a name that promises more contradiction than the numbers alone reveal.
Where to Buy Seeds
We may earn a commission from purchases made through these links.
Frequently Asked Questions about Sonoma Coma
Is Sonoma Coma an Indica, Sativa, or Hybrid?
Sonoma Coma is classified as a hybrid cannabis strain.
What cannabinoid content is reported for Sonoma Coma?
Sonoma Coma: 19% THC and 0.6% CBD reported in our data. The THC figure, when present, is the upper end of the reported range, not a typical measured dose. Potency can vary across harvests, phenotypes, and growing conditions.